Ben-Noon Alon 13D and 13G filings for NeuroSense Therapeutics Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 10:14 am Purchase |
2023-12-31 | 13G | NeuroSense Therapeutics Ltd. NRSN |
Ben-Noon Alon | 3,072,600 19.980% |
36,000 (+1.19%) |
Filing |
| 2023-04-05 08:02 am Purchase |
2022-12-31 | 13G | NeuroSense Therapeutics Ltd. NRSN |
Ben-Noon Alon | 3,036,600 25.770% |
36,000 (+1.20%) |
Filing |
| 2021-12-23 5:03 pm Purchase |
2021-12-13 | 13G | NeuroSense Therapeutics Ltd. NRSN |
Ben-Noon Alon | 3,000,600 27.420% |
3,000,600 (New Position) |
Filing |